Announcements

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Survivorship and Quality of Life”, which are listed below:

1. “Depression, Inflammation, and Intestinal Permeability: Associations with Subjective and Objective Cognitive Functioning throughout Breast Cancer Survivorship”
by Annelise A. Madison, Rebecca Andridge, Anthony H. Kantaras, Megan E. Renna, Jeanette M. Bennett, Catherine M. Alfano, Stephen P. Povoski, Doreen M. Agnese, Maryam Lustberg, Robert Wesolowski et al.
Cancers 2023, 15(17), 4414; https://doi.org/10.3390/cancers15174414
Available online: https://www.mdpi.com/2072-6694/15/17/4414

2. “First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive Function”
by Jamie S. Myers, Adam C. Parks, Jonathan D. Mahnken, Kate J. Young, Harsh B. Pathak, Rajni V. Puri, Amber Unrein, Phyllis Switzer, Yazan Abdulateef, Samantha Sullivan et al.
Cancers 2023, 15(5), 1615; https://doi.org/10.3390/cancers15051615
Available online: https://www.mdpi.com/2072-6694/15/5/1615

3. “Characteristics and Components of Self-Management Interventions for Improving Quality of Life in Cancer Survivors: A Systematic Review”
by Ben Rimmer, Morven C. Brown, Tumi Sotire, Fiona Beyer, Iakov Bolnykh, Michelle Balla, Catherine Richmond, Lizzie Dutton, Sophie Williams, Vera Araújo-Soares et al.
Cancers 2024, 16(1), 14; https://doi.org/10.3390/cancers16010014
Available online: https://www.mdpi.com/2072-6694/16/1/14

4. “The Association between the Gut Microbiome and Development and Progression of Cancer Treatment Adverse Effects”
by Amanda S. Maddern, Janet K. Coller, Joanne M. Bowen and Rachel J. Gibson
Cancers 2023, 15(17), 4301; https://doi.org/10.3390/cancers15174301
Available online: https://www.mdpi.com/2072-6694/15/17/4301

5. “The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity”
by Argyro Papadopetraki, Antonios Giannopoulos, Maria Maridaki, Flora Zagouri, Stavroula Droufakou, Michael Koutsilieris and Anastassios Philippou
Cancers 2023, 15(24), 5856; https://doi.org/10.3390/cancers15245856
Available online: https://www.mdpi.com/2072-6694/15/24/5856

6. “Preoperative CT-Based Skeletal Muscle Mass Depletion and Outcomes after Total Laryngectomy”
by Victoria Salati, Katerina Mandralis, Fabio Becce, Joachim Koerfer, Karma Lambercy, Christian Simon and François Gorostidi
Cancers 2023, 15(14), 3538; https://doi.org/10.3390/cancers15143538
Available online: https://www.mdpi.com/2072-6694/15/14/3538

7. “Consumer Perspectives on the Adoption of a Prehabilitation Multimodal Online Program for Patients Undergoing Cancer Surgery”
by Daniel Steffens, Linda Denehy, Michael Solomon, Cherry Koh, Nabila Ansari, Kate McBride, Sharon Carey, Jenna Bartyn, Aaron Sean Lawrence, Kym Sheehan et al.
Cancers 2023, 15(20), 5039; https://doi.org/10.3390/cancers15205039
Available online: https://www.mdpi.com/2072-6694/15/20/5039

8. “A Novel Score Using Lymphocyte-to-Monocyte Ratio in Blood and Malignant Body Fluid for Predicting Prognosis of Patients with Advanced Ovarian Cancer”
by Min Jin Jeong, Yeo Nyeong Yoon, Yeon Kyung Kang, Chan Joo Kim, Hae Seong Nam and Yong Seok Lee
Cancers 2023, 15(8), 2328; https://doi.org/10.3390/cancers15082328
Available online: https://www.mdpi.com/2072-6694/15/8/2328

9. “Assessing the Needs of Those Who Serve the Underserved: A Qualitative Study among US Oncology Clinicians”
by Manali I. Patel, Leslie Hinyard, Fay J. Hlubocky, Janette K. Merrill, Kimberly T. Smith, Sailaja Kamaraju, Daniel Carrizosa, Tricia Kalwar, Lola Fashoyin-Aje, Scarlett L. Gomez et al.
Cancers 2023, 15(13), 3311; https://doi.org/10.3390/cancers15133311
Available online: https://www.mdpi.com/2072-6694/15/13/3311

10. “Patient-Reported Mobility, Physical Activity, and Bicycle Use after Vulvar Carcinoma Surgery”
by Nick J. van de Berg, Franciscus P. van Beurden, G. C. Wanda Wendel-Vos, Marjolein Duijvestijn, Heleen J. van Beekhuizen, Marianne Maliepaard and Helena C. van Doorn
Cancers 2023, 15(8), 2324; https://doi.org/10.3390/cancers15082324
Available online: https://www.mdpi.com/2072-6694/15/8/2324

11. “Colorectal Cancer Surgery: Influence of Psychosocial Factors”
by Regina Moldes-Moro and María José de Dios-Duarte
Cancers 2023, 15(16), 4140; https://doi.org/10.3390/cancers15164140
Available online: https://www.mdpi.com/2072-6694/15/16/4140

12. “Complications of Central Venous Access Devices Used in Palliative Care Settings for Terminally Ill Cancer Patients: A Systematic Review and Meta-Analysis”
by Clement Chun-Him Wong, Horace Cheuk-Wai Choi and Victor Ho-Fun Lee
Cancers 2023, 15(19), 4712; https://doi.org/10.3390/cancers15194712
Available online: https://www.mdpi.com/2072-6694/15/19/4712

13. “Predicting Long-Term Care Service Demands for Cancer Patients: A Machine Learning Approach”
by Shuo-Chen Chien, Yu-Hung Chang, Chia-Ming Yen, Ying-Erh Chen, Chia-Chun Liu, Yu-Ping Hsiao, Ping-Yen Yang, Hong-Ming Lin, Xing-Hua Lu, I-Chien Wu et al.
Cancers 2023, 15(18), 4598; https://doi.org/10.3390/cancers15184598
Available online: https://www.mdpi.com/2072-6694/15/18/4598

14. “Treatment of Colorectal Cancer in Certified Centers: Results of a Large German Registry Study Focusing on Long-Term Survival”
by Vinzenz Völkel, Michael Gerken, Kees Kleihues-van Tol, Olaf Schoffer, Veronika Bierbaum, Christoph Bobeth, Martin Roessler, Christoph Reissfelder, Alois Fürst, Stefan Benz et al.
Cancers 2023, 15(18), 4568; https://doi.org/10.3390/cancers15184568
Available online: https://www.mdpi.com/2072-6694/15/18/4568

15. “Immunotherapy-Related Oral Adverse Effects: Immediate Sequelae, Chronicity and Secondary Cancer”
by Sharon Elad, Noam Yarom and Yehuda Zadik
Cancers 2023, 15(19), 4781; https://doi.org/10.3390/cancers15194781
Available online: https://www.mdpi.com/2072-6694/15/19/4781

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in Section “Cancer Therapy” which are listed below.

1. “The Current Status of Photodynamic Therapy in Cancer Treatment”
by Wenqi Jiang, Mingkang Liang, Qifang Lei, Guangzhi Li and Song Wu
Cancers 2023, 15(3), 585; https://doi.org/10.3390/cancers15030585
Available online: https://www.mdpi.com/2072-6694/15/3/585

2. “A Recent Review on Cancer Nanomedicine”
by Paras Mani Giri, Anurag Banerjee and Buddhadev Layek
Cancers 2023, 15(8), 2256; https://doi.org/10.3390/cancers15082256  
Available online: https://www.mdpi.com/2072-6694/15/8/2256

3. “Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input”
by Valentine Wang, Mélanie Gauthier, Véronique Decot, Loïc Reppel and Danièle Bensoussan
Cancers 2023, 15(4), 1003; https://doi.org/10.3390/cancers15041003
Available online: https://www.mdpi.com/2072-6694/15/4/1003

4. “Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge”
by Wing Sum Shin, Fuda Xie, Bonan Chen, Peiyao Yu, Jun Yu, Ka Fai To and Wei Kang
Cancers 2023, 15(9), 2639; https://doi.org/10.3390/cancers15092639   
Available online: https://www.mdpi.com/2072-6694/15/9/2639

5. “Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments”
by Marine Valery, Damien Vasseur, Francesco Fachinetti, Alice Boilève, Cristina Smolenschi, Anthony Tarabay, Leony Antoun, Audrey Perret, Alina Fuerea, Thomas Pudlarz et al.
Cancers 2023, 15(18), 4446; https://doi.org/10.3390/cancers15184446  
Available online: https://www.mdpi.com/2072-6694/15/18/4446

6. “CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression”
by Andrew S. Luksik, Eli Yazigi, Pavan Shah and Christopher M. Jackson
Cancers 2023, 15(5), 1414; https://doi.org/10.3390/cancers15051414  
Available online: https://www.mdpi.com/2072-6694/15/5/1414

7. “Prognostic Values of Systemic Inflammatory Immunological Markers in Glioblastoma: A Systematic Review and Meta-Analysis”
by Pawel Jarmuzek, Klaudia Kozlowska, Piotr Defort, Marcin Kot and Agnieszka Zembron-Lacny
Cancers 2023, 15(13), 3339; https://doi.org/10.3390/cancers15133339  
Available online: https://www.mdpi.com/2072-6694/15/13/3339

8. “Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma”
by Borja Puertas, Verónica González-Calle, Eduardo Sobejano-Fuertes, Fernando Escalante, José A. Queizán, Abelardo Bárez, Jorge Labrador, José María Alonso-Alonso, Alfonso García de Coca, Alberto Cantalapiedra et al.
Cancers 2023, 15(5), 1558; https://doi.org/10.3390/cancers15051558
Available online: https://www.mdpi.com/2072-6694/15/5/1558

9. “Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies”
by Justin H. Lo, Rajiv Agarwal, Laura W. Goff and Thatcher R. Heumann
Cancers 2023, 15(13), 3312; https://doi.org/10.3390/cancers15133312
Available online: https://www.mdpi.com/2072-6694/15/13/3312

10. “MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities”
by Kang Qin, Lingzhi Hong, Jianjun Zhang and Xiuning Le
Cancers 2023, 15(3), 612; https://doi.org/10.3390/cancers15030612  
Available online: https://www.mdpi.com/2072-6694/15/3/612

11. “Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations”
by Olga Partyka, Monika Pajewska, Daria Kwaśniewska, Aleksandra Czerw, Andrzej Deptała, Michał Budzik, Elżbieta Cipora, Izabela Gąska, Lucyna Gazdowicz, Aneta Mielnik et al.
Cancers 2023, 15(14), 3634; https://doi.org/10.3390/cancers15143634  
Available online: https://www.mdpi.com/2072-6694/15/14/3634

12. “BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers”
by Giorgia Castellani, Mariachiara Buccarelli, Maria Beatrice Arasi, Stefania Rossi, Maria Elena Pisanu, Maria Bellenghi, Carla Lintas and Claudio Tabolacci
Cancers 2023, 15(16), 4026; https://doi.org/10.3390/cancers15164026
Available online: https://www.mdpi.com/2072-6694/15/16/4026

13. “10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis”
by Andrea Di Giorgio, Antonio Macrì, Federica Ferracci, Manuela Robella, Mario Visaloco, Giovanni De Manzoni, Paolo Sammartino, Antonio Sommariva, Daniele Biacchi, Franco Roviello et al.
Cancers 2023, 15(4), 1125; https://doi.org/10.3390/cancers15041125  
Available online: https://www.mdpi.com/2072-6694/15/4/1125

14. “Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma”
by Chia-Chi Yeh, Huang-Kai Kao, Yenlin Huang, Tsung-You Tsai, Chi-Kuang Young, Shao-Yu Hung, Chuieng-Yi Lu and Kai-Ping Chang
Cancers 2023, 15(1), 322; https://doi.org/10.3390/cancers15010322
Available online: https://www.mdpi.com/2072-6694/15/1/322

15. “The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy”
by Ester Orlandi, Amelia Barcellini, Barbara Vischioni, Maria Rosaria Fiore, Viviana Vitolo, Alberto Iannalfi, Maria Bonora, Agnieszka Chalaszczyk, Rossana Ingargiola, Giulia Riva et al.
Cancers 2023, 15(20), 5068; https://doi.org/10.3390/cancers15205068  
Available online: https://www.mdpi.com/2072-6694/15/20/5068

16. “Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers”
by Sebastian O. Oloo, Kevin M. Smith and Maria da Graça H. Vicente
Cancers 2023, 15(13), 3277; https://doi.org/10.3390/cancers15133277
Available online: https://www.mdpi.com/2072-6694/15/13/3277

17. “The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma—A Systematic Review”
by Kevin Parza, Arfa Mustasam, Filip Ionescu, Mahati Paravathaneni, Reagan Sandstrom, Houssein Safa, G. Daniel Grass, Peter A. Johnstone, Steven A. Eschrich, Juskaran Chadha et al.
Cancers 2023, 15(14), 3713; https://doi.org/10.3390/cancers15143713  
Available online: https://www.mdpi.com/2072-6694/15/14/3713

18. “Exploring the Past, Present, and Future of Anti-Angiogenic Therapy in Glioblastoma”
by Ashley B. Zhang, Khashayar Mozaffari, Brian Aguirre, Victor Li, Rohan Kubba, Nilay C. Desai, Darren Wei, Isaac Yang and Madhuri Wadehra
Cancers 2023, 15(3), 830; https://doi.org/10.3390/cancers15030830  
Available online: https://www.mdpi.com/2072-6694/15/3/830

19. “Image-Guided Proton Therapy: A Comprehensive Review”
by Shelby A. Lane, Jason M. Slater and Gary Y. Yang
Cancers 2023, 15(9), 2555; https://doi.org/10.3390/cancers15092555  
Available online: https://www.mdpi.com/2072-6694/15/9/2555

20. “Senolytic Flavonoids Enhance Type-I and Type-II Cell Death in Human Radioresistant Colon Cancer Cells through AMPK/MAPK Pathway”
by Maria Russo, Stefania Moccia, Diomira Luongo and Gian Luigi Russo
Cancers 2023, 15(9), 2660, https://doi.org/10.3390/cancers15092660  
Available online: https://www.mdpi.com/2072-6694/15/9/2660

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Infectious Agents and Cancer”, which are listed below:

1. “Intestinal Microbes and Hematological Malignancies”
by Yinghong Zhu, Qiaohui Yang, Qin Yang, Yanjuan He and Wen Zhou
Cancers 2023, 15(8), 2284; https://doi.org/10.3390/cancers15082284
Available online: https://www.mdpi.com/2072-6694/15/8/2284

2. “Overexpression of E6/E7 mRNA HPV Is a Prognostic Biomarker for Residual Disease Progression in Women Undergoing LEEP for Cervical Intraepithelial Neoplasia 3”
by Maria Teresa Bruno, Giulia Bonanno, Francesco Sgalambro, Antonino Cavallaro and Sara Boemi
Cancers 2023, 15(17), 4203; https://doi.org/10.3390/cancers15174203
Available online: https://www.mdpi.com/2072-6694/15/17/4203

3. “Unveiling the Association between HPV and Pan-Cancers: A Bidirectional Two-Sample Mendelian Randomization Study”
by Jianxuan Sun, Jiacheng Xiang, Ye An, Jinzhou Xu, Yifan Xiong, Shaogang Wang and Qidong Xia
Cancers 2023, 15(21), 5147; https://doi.org/10.3390/cancers15215147
Available online: https://www.mdpi.com/2072-6694/15/21/5147

4. “Study of Helicobacter pylori Isolated from a High-Gastric-Cancer-Risk Population: Unveiling the Comprehensive Analysis of Virulence-Associated Genes including Secretion Systems, and Genome-Wide Association Study”
by Batsaikhan Saruuljavkhlan, Ricky Indra Alfaray, Khasag Oyuntsetseg, Boldbaatar Gantuya, Ayush Khangai, Namsrai Renchinsengee, Takashi Matsumoto, Junko Akada, Dashdorj Azzaya, Duger Davaadorj et al.
Cancers 2023, 15(18), 4528; https://doi.org/10.3390/cancers15184528
Available online: https://www.mdpi.com/2072-6694/15/18/4528

5. “Oral Bacteria, Virus and Fungi in Saliva and Tissue Samples from Adult Subjects with Oral Squamous Cell Carcinoma: An Umbrella Review”
by Federica Di Spirito, Maria Pia Di Palo, Veronica Folliero, Davide Cannatà, Gianluigi Franci, Stefano Martina and Massimo Amato
Cancers 2023, 15(23), 5540; https://doi.org/10.3390/cancers15235540
Available online: https://www.mdpi.com/2072-6694/15/23/5540

6. “Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology”
by Karolina Mazurec, Martyna Trzeszcz, Maciej Mazurec, Joanna Streb, Agnieszka Halon and Robert Jach
Cancers 2023, 15(20), 5095; https://doi.org/10.3390/cancers15205095
Available online: https://www.mdpi.com/2072-6694/15/20/5095

7. “Microbial-Related Metabolites May Be Involved in Eight Major Biological Processes and Represent Potential Diagnostic Markers in Gastric Cancer”
by Siru Nie, Ang Wang, Xiaohui Chen, Yuehua Gong and Yuan Yuan
Cancers 2023, 15(21), 5271; https://doi.org/10.3390/cancers15215271
Available online: https://www.mdpi.com/2072-6694/15/21/5271

8. “Changing Prevalence of AIDS and Non-AIDS-Defining Cancers in an Incident Cohort of People Living with HIV over 28 Years”
by Anna Maria Cattelan, Maria Mazzitelli, Nicolò Presa, Claudia Cozzolino, Lolita Sasset, Davide Leoni, Beatrice Bragato, Vincenzo Scaglione, Vincenzo Baldo and Saverio Giuseppe Parisi
Cancers 2024, 16(1), 70; https://doi.org/10.3390/cancers16010070
Available online: https://www.mdpi.com/2072-6694/16/1/70

9. “Prevalence and Characteristics of Human Papillomavirus Infection in Oropharyngeal Squamous Cell Papilloma”
by Dongbin Ahn, Ji-Hye Kwak, Gil-Joon Lee and Jin-Ho Sohn
Cancers 2023, 15(3), 810; https://doi.org/10.3390/cancers15030810
Available online: https://www.mdpi.com/2072-6694/15/3/810

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Tumor Microenvironment”, which are listed below:

1. “5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL⁺ Cytotoxic T Lymphocyte Cytotoxicity”
by Yingcui Yang, Mingqing Zhang, Yongdan Zhang, Kebin Liu and Chunwan Lu
Cancers 2023, 15(5), 1563; https://doi.org/10.3390/cancers15051563
Available online: https://www.mdpi.com/2072-6694/15/5/1563

2. “Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment”
by Yasushi Shintani, Toru Kimura, Soichiro Funaki, Naoko Ose, Takashi Kanou and Eriko Fukui
Cancers 2023, 15(2), 335; https://doi.org/10.3390/cancers15020335
Available online: https://www.mdpi.com/2072-6694/15/2/335

3. “Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue”
by Yoshimi Arima, Satoko Matsueda and Hideyuki Saya
Cancers 2023, 15(9), 2536; https://doi.org/10.3390/cancers15092536
Available online: https://www.mdpi.com/2072-6694/15/9/2536

4. “Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1”
by Weili Tao, Ze Ouyang, Zhiqi Liao, Lu Li, Yujie Zhang, Jiali Gao, Li Ma and Shiying Yu
Cancers 2023, 15(8), 2378; https://doi.org/10.3390/cancers15082378
Available online: https://www.mdpi.com/2072-6694/15/8/2378

5. “Targeting Iron-Sulfur Clusters in Cancer: Opportunities and Challenges for Ferroptosis-Based Therapy”
by Jaewang Lee and Jong-Lyel Roh
Cancers 2023, 15(10), 2694; https://doi.org/10.3390/cancers15102694
Available online: https://www.mdpi.com/2072-6694/15/10/2694

6. “CD44 Intracellular Domain: A Long Tale of a Short Tail”
by Spyros S. Skandalis
Cancers 2023, 15(20), 5041; https://doi.org/10.3390/cancers15205041
Available online: https://www.mdpi.com/2072-6694/15/20/5041

7. “Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors”
by Eleonora Boscaro, Irene Urbino, Federica Maria Catania, Giulia Arrigo, Carolina Secreto, Matteo Olivi, Stefano D’Ardia, Chiara Frairia, Valentina Giai, Roberto Freilone et al.
Cancers 2023, 15(13), 3512; https://doi.org/10.3390/cancers15133512
Available online: https://www.mdpi.com/2072-6694/15/13/3512

8. “Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression”
by Gabor Dobos, Ingrid Lazaridou and Adèle de Masson
Cancers 2023, 15(3), 746; https://doi.org/10.3390/cancers15030746
Available online: https://www.mdpi.com/2072-6694/15/3/746

9. “Efficient Brain Tumor Detection with Lightweight End-to-End Deep Learning Model”
by Mohamed Hammad, Mohammed ElAffendi, Abdelhamied A. Ateya and Ahmed A. Abd El-Latif
Cancers 2023, 15(10), 2837; https://doi.org/10.3390/cancers15102837
Available online: https://www.mdpi.com/2072-6694/15/10/2837

10. “Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy”
by Maozhen Peng, Ying Ying, Zheng Zhang, Liang Liu and Wenquan Wang
Cancers 2023, 15(9), 2448; https://doi.org/10.3390/cancers15092448
Available online: https://www.mdpi.com/2072-6694/15/9/2448

11. “The Three-Dimensional In Vitro Cell Culture Models in the Study of Oral Cancer Immune Microenvironment”
by Elaheh Dalir Abdolahinia and Xiaozhe Han
Cancers 2023, 15(17), 4266; https://doi.org/10.3390/cancers15174266
Available online: https://www.mdpi.com/2072-6694/15/17/4266

12. “Highly Metastatic Subpopulation of TNBC Cells Has Limited Iron Metabolism and Is a Target of Iron Chelators”
by Yuze Wang, Toshiaki Ohara, Yuehua Chen, Yusuke Hamada, Chunning Li, Masayoshi Fujisawa, Teizo Yoshimura and Akihiro Matsukawa
Cancers 2023, 15(2), 468; https://doi.org/10.3390/cancers15020468
Available online: https://www.mdpi.com/2072-6694/15/2/468

13. “The Extracellular Matrix in Glioblastomas: A Glance at Its Structural Modifications in Shaping the Tumoral Microenvironment—A Systematic Review”
by Salvatore Marino, Grazia Menna, Rina Di Bonaventura, Lucia Lisi, Pierpaolo Mattogno, Federica Figà, Lal Bilgin, Quintino Giorgio D’Alessandris, Alessandro Olivi and Giuseppe Maria Della Pepa
Cancers 2023, 15(6), 1879; https://doi.org/10.3390/cancers15061879
Available online: https://www.mdpi.com/2072-6694/15/6/1879

14. “Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers”
by Javier Ros, Iosune Baraibar, Nadia Saoudi, Marta Rodriguez, Francesc Salvà, Josep Tabernero and Elena Élez
Cancers 2023, 15(17), 4245; https://doi.org/10.3390/cancers15174245
Available online: https://www.mdpi.com/2072-6694/15/17/4245

15. “Important Cells and Factors from Tumor Microenvironment Participated in Perineural Invasion”
by Zirong Chen, Yan Fang and Weihong Jiang
Cancers 2023, 15(5), 1360; https://doi.org/10.3390/cancers15051360
Available online: https://www.mdpi.com/2072-6694/15/5/1360

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

July is designated as Sarcoma and Bone Cancer Awareness Month, with various global activities that highlight and increase awareness of sarcoma and bone cancer for research support and development.

We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of sarcoma and bone cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant papers can be seen below.

“Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings”
by Jun-Ho Kim and Seul Ki Lee
Cancers 2023, 15(6), 1703; https://doi.org/10.3390/cancers15061703
Available online: https://www.mdpi.com/2072-6694/15/6/1703

“Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin”
by Valentina Fausti , Alessandro De Vita, Silvia Vanni, Virginia Ghini, Lorena Gurrieri, Nada Riva, Roberto Casadei, Marco Maraldi, Giorgio Ercolani, Davide Cavaliere et al.
Cancers 2023, 15(4), 1080; https://doi.org/10.3390/cancers15041080
Available online: https://www.mdpi.com/2072-6694/15/4/1080

“Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions”
by Antoine Gilbert, Mihaela Tudor, Juliette Montanari, Kevin Commenchail, Diana Iulia Savu, Paul Lesueur and François Chevalier
Cancers 2023, 15(7), 1962; https://doi.org/10.3390/cancers15071962
Available online: https://www.mdpi.com/2072-6694/15/7/1962

“Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma”
by Liangkun Huang, Fei Sun, Zilin Liu, Wenyi Jin, Yubiao Zhang, Junwen Chen, Changheng Zhong,
Wanting Liang and Hao Peng
Cancers 2023, 15(8), 2405; https://doi.org/10.3390/cancers15082405
Available online: https://www.mdpi.com/2072-6694/15/8/2405

“Anti-Invasive and Anti-Migratory Effects of Ononin on Human Osteosarcoma Cells by Limiting the MMP2/9 and EGFR-Erk1/2 Pathway”
by Guowei Gong, Kumar Ganesan, Qingping Xiong and Yuzhong Zheng
Cancers 2023, 15(3), 758; https://doi.org/10.3390/cancers15030758
Available online: https://www.mdpi.com/2072-6694/15/3/758

“SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma”
by Erlinda Maria Gordon, Sant P. Chawla, Walter Andree Tellez, Elan Younesi, Sonu Thomas, Victoria S. Chua-Alcala, Hripsime Chomoyan, Chrysler Valencia, Don Arlen Brigham and Ania Moradkhani
Cancers 2023, 15(3), 906; https://doi.org/10.3390/cancers15030906
Available online: https://www.mdpi.com/2072-6694/15/3/906

“Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design”
by Bradford S. Hoppe, Ivy A. Petersen, Benjamin K. Wilke, Todd A. DeWees, Reiko Imai, Eugen B. Hug, Maria Rosaria Fiore, Jürgen Debus, Piero Fossati and Shigeru Yamada
Cancers 2023, 15(6), 1660; https://doi.org/10.3390/cancers15061660
Available online: https://www.mdpi.com/2072-6694/15/6/1660

“Intraoperative Evaluation of Soft Tissue Sarcoma Surgical Margins with Indocyanine Green Fluorescence Imaging”
by Matthew F. Gong, William T. Li, Sumail Bhogal, Brittany Royes, Tanya Heim, Maria Silvaggio, Marcus Malek, Rajeev Dhupar, Stella J. Lee, Richard L. McGough and Kurt R. Weiss
Cancers 2023, 15(3), 582; https://doi.org/10.3390/cancers15030582
Available online: www.mdpi.com/2072-6694/15/3/582

“CT and MR Imaging of Retroperitoneal Sarcomas: A Practical Guide for the Radiologist”
by Giorgia Porrello, Roberto Cannella, Angelo Randazzo, Giuseppe Badalamenti, Giuseppe Brancatelli and Federica Vernuccio
Cancers 2023, 15(11), 2985; https://doi.org/10.3390/cancers15112985
Available online: https://www.mdpi.com/2072-6694/15/11/2985

“Synovial Sarcoma in the Extremity: Diversity of Imaging Features for Diagnosis and Prognosis”
by Eun Byul Cho, Seul Ki Lee, Jee-Young Kim and Yuri Kim
Cancers 2023, 15(19), 4860; https://doi.org/10.3390/cancers15194860
Available online: https://www.mdpi.com/2072-6694/15/19/4860

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Drug Development”, which are listed below:

1. “Nature’s Green Potential: Anticancer Properties of Plants of the Euphorbiaceae Family”
by Víctor Jiménez-González, Tomasz Kowalczyk, Janusz Piekarski, Janusz Szemraj, Patricia Rijo and Przemysław Sitarek
Cancers 2024, 16(1), 114; https://doi.org/10.3390/cancers16010114
Available online: https://www.mdpi.com/2072-6694/16/1/114

2. “Role of c-Src in Carcinogenesis and Drug Resistance”
by Lukmon Raji, Angelina Tetteh and A. R. M. Ruhul Amin
Cancers 2024, 16(1), 32; https://doi.org/10.3390/cancers16010032
Available online: https://www.mdpi.com/2072-6694/16/1/32

3. “Modulation of Notch Signaling by Small-Molecular Compounds and Its Potential in Anticancer Studies”
by Arkadiusz Czerwonka, Joanna Kałafut and Matthias Nees
Cancers 2023, 15(18), 4563; https://doi.org/10.3390/cancers15184563
Available online: https://www.mdpi.com/2072-6694/15/18/4563

4. “MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential”
by Junjiang Fu, Saber Imani, Mei-Yi Wu and Ray-Chang Wu
Cancers 2023, 15(19), 4723; https://doi.org/10.3390/cancers15194723
Available online: https://www.mdpi.com/2072-6694/15/19/4723

5. “SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy”
by Yan Sun, Xudong Liu, Hang Tong, Hubin Yin, Tinghao Li, Junlong Zhu, Junrui Chen, Linfeng Wu, Xiaoyu Zhang, Xin Gou et al.
Cancers 2024, 16(1), 125; https://doi.org/10.3390/cancers16010125
Available online: https://www.mdpi.com/2072-6694/16/1/125

6. “Challenges and Future Directions in the Management of Tumor Mutational Burden-High (TMB-H) Advanced Solid Malignancies”
by Jibran Ahmed, Biswajit Das, Sarah Shin and Alice Chen
Cancers 2023, 15(24), 5841; https://doi.org/10.3390/cancers15245841
Available online: https://www.mdpi.com/2072-6694/15/24/5841

7. “Mutation Status and Glucose Availability Affect the Response to Mitochondria-Targeted Quercetin Derivative in Breast Cancer Cells”
by Paweł Przybylski, Anna Lewińska, Iwona Rzeszutek, Dominika Błoniarz, Aleksandra Moskal, Gabriela Betlej, Anna Deręgowska, Martyna Cybularczyk-Cecotka, Tomasz Szmatoła, Grzegorz Litwinienko et al.
Cancers 2023, 15(23), 5614; https://doi.org/10.3390/cancers15235614
Available online: https://www.mdpi.com/2072-6694/15/23/5614

8. “Prediction of ¹⁷⁷Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on ⁶⁸Ga-DOTATATE PET/CT”
by Hwan Lee, Sarit T. Kipnis, Remy Niman, Sophia R. O’Brien, Jennifer R. Eads, Bryson W. Katona and Daniel A. Pryma
Cancers 2024, 16(1), 200; https://doi.org/10.3390/cancers16010200
Available online: https://www.mdpi.com/2072-6694/16/1/200

9. “STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs”
by Mircea T. Chiriac, Zsuzsanna Hracsko, Christoph Becker and Markus F. Neurath
Cancers 2023, 15(22), 5423; https://doi.org/10.3390/cancers15225423
Available online: https://www.mdpi.com/2072-6694/15/22/5423

10. “First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors”
by Anna R. Schreiber, Jodi A. Kagihara, Bradley R. Corr, S. Lindsey Davis, Christopher Lieu, Sunnie S. Kim, Antonio Jimeno, D. Ross Camidge, Jud Williams, Amy M. Heim et al.
Cancers 2024, 16(1), 91; https://doi.org/10.3390/cancers16010091
Available online: https://www.mdpi.com/2072-6694/16/1/91

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

We are pleased to invite you to read the highly cited papers in 2023 in Cancers (ISSN: 2072-6694) in the Section “Clinical Research of Cancer”. The list of relevant papers can be seen below.

“The Evolving Role of Cryosurgery in Breast Cancer Management: A Comprehensive Review”
by Kefah Mokbel, Alevtina Kodresko, Heba Ghazal, Ramia Mokbel, Jon Trembley and Hussam Jouhara
Cancers 2023, 15(17), 4272; https://doi.org/10.3390/cancers15174272
Available online: https://www.mdpi.com/2072-6694/15/17/4272

“Interstitial Photodynamic Therapy of Glioblastomas: A Long-Term Follow-up Analysis of Survival and Volumetric MRI Data”
by Marco Foglar, Maximilian Aumiller, Katja Bochmann, Alexander Buchner, Mohamed El Fahim, Stefanie Quach, Ronald Sroka, Herbert Stepp, Niklas Thon, Robert Forbrig et al.
Cancers 2023, 15(9), 2603; https://doi.org/10.3390/cancers15092603
Available online: https://www.mdpi.com/2072-6694/15/9/2603

“Osteosarcoma in Pediatric and Adult Populations: Are Adults Just Big Kids?”
by Caleb Kim, Lara E. Davis, Catherine M. Albert, Brian Samuels, Jesse L. Roberts and Michael J. Wagner
Cancers 2023, 15(20), 5044; https://doi.org/10.3390/cancers15205044
Available online: https://www.mdpi.com/2072-6694/15/20/5044

“World’s First Long-Term Colorectal Cancer Model by 3D Bioprinting as a Mechanism for Screening Oncolytic Viruses”
by Colin McGuckin, Nico Forraz, Clément Milet, Mathieu Lacroix, Yordan Sbirkov, Victoria Sarafian, Caroline Ebel, Anita Spindler, Véronique Koerper, Jean-Marc Balloul et al.
Cancers 2023, 15(19), 4724; https://doi.org/10.3390/cancers15194724
Available online: https://www.mdpi.com/2072-6694/15/19/4724

“A Novel Methylation Marker NRN1 plus TERT and FGFR3 Mutation Using Urine Sediment Enables the Detection of Urothelial Bladder Carcinoma”
by Junjie Zhang, Ran Xu, Qiang Lu, Zhenzhou Xu, Jianye Liu, Pei Li, Yaqun Zhang, Chuanchi Zhou, Lufeng Luo, Wei Tang et al.
Cancers 2023, 15(3), 615; https://doi.org/10.3390/cancers15030615
Available online: https://www.mdpi.com/2072-6694/15/3/615

“Maternal Cancer and Perception of Child Psychological Adjustment: The Role of Mother’s Anxiety, Depression, and Parenting Stress”
by Alessandra Babore, Carmen Trumello, Tânia Brandão, Alessandra Cavallo and Sonia Monique Bramanti
Cancers 2023, 15(3), 910; https://doi.org/10.3390/cancers15030910
Available online: https://www.mdpi.com/2072-6694/15/3/910

“An Updated Review of the Biomarkers of Response to Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: Merkel Cell Carcinoma and Immunotherapy”
by Adnan Fojnica, Kenana Ljuca, Saghir Akhtar, Zoran Gatalica and Semir Vranic
Cancers 2023, 15(20), 5084; https://doi.org/10.3390/cancers15205084
Available online: https://www.mdpi.com/2072-6694/15/20/5084

“Selecting a TNT Schedule in Locally Advanced Rectal Cancer: Can We Predict Who Actually Benefits?”
by Carlo Aschele and Robert Glynne-Jones
Cancers 2023, 15(9), 2567; https://doi.org/10.3390/cancers15092567
Available online: https://www.mdpi.com/2072-6694/15/9/2567

“Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression””
by Mathilde Bausart, Elia Bozzato, Nicolas Joudiou, Xanthippi Koutsoumpou, Bella Manshian, Véronique Préat and Bernard Gallez
Cancers 2023, 15(6), 1919; https://doi.org/10.3390/cancers15061919
Available online: https://www.mdpi.com/2072-6694/15/6/1919

“Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study”
by Eric Leblanc, Fabrice Narducci, Gwenaël Ferron, Audrey Mailliez, Jean-Yves Charvolin, El Hajj Houssein, Frédéric Guyon, Virginie Fourchotte, Eric Lambaudie, Agathe Crouzet et al.
Cancers 2023, 15(4), 1141; https://doi.org/10.3390/cancers15041141
Available online: https://www.mdpi.com/2072-6694/15/4/1141

“Rectal Sparing Approaches after Neoadjuvant Treatment for Rectal Cancer: A Systematic Review and Meta-Analysis Comparing Local Excision and Watch and Wait”
by Quoc Riccardo Bao, Stefania Ferrari, Giulia Capelli, Cesare Ruffolo, Marco Scarpa, Amedea Agnes, Giuditta Chiloiro, Elisa Palazzari, Emanuele Damiano Luca Urso, Salvatore Pucciarelli et al.
Cancers 2023, 15(2), 465; https://doi.org/10.3390/cancers15020465
Available online: https://www.mdpi.com/2072-6694/15/2/465

“Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study”
by Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, Valerio Gaetano Vellone, Alessio Signori, Fabio Catalano, Alessandra Damassi, Gabriele Gaggero, Pasquale Rescigno, Marco Maruzzo et al.
Cancers 2023, 15(8), 2394; https://doi.org/10.3390/cancers15082394
Available online: https://www.mdpi.com/2072-6694/15/8/2394

“Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre”
by Mark Stares, Georgina Lewis, Maheva Vallet, Angus Killean, Giovanni Tramonti, Ailsa Patrizio, Melanie Mackean, Stephen Harrow, Colin Barrie, Kirsty MacLennan et al.
Cancers 2023, 15(5), 1431; https://doi.org/10.3390/cancers15051431
Available online: https://www.mdpi.com/2072-6694/15/5/1431

“The Current State of Neoadjuvant Therapy in Resectable Advanced Stage Melanoma”
by Omar Bushara, Jerica Tidwell, James R. Wester and John Miura
Cancers 2023, 15(13), 3344; https://doi.org/10.3390/cancers15133344
Available online: https://www.mdpi.com/2072-6694/15/13/3344

“De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?”
by Claudia Piombino, Marco Oltrecolli, Elena Tonni, Marta Pirola, Rossana Matranga, Cinza Baldessari, Stefania Pipitone, Massimo Dominici, Roberto Sabbatini and Maria Giuseppa Vitale
Cancers 2023, 15(20), 4945; https://doi.org/10.3390/cancers15204945
Available online: https://www.mdpi.com/2072-6694/15/20/4945

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Molecular Cancer Biology”, which are listed below:

1. “Challenges and Prospects of Patient-Derived Xenografts for Cancer Research”
by Jiankang Jin, Katsuhiro Yoshimura, Matheus Sewastjanow-Silva, Shumei Song and Jaffer A. Ajani
Cancers 2023, 15(17), 4352; https://doi.org/10.3390/cancers15174352
Available online: https://www.mdpi.com/2072-6694/15/17/4352

2. “EZH2: An Accomplice of Gastric Cancer”
by Wuhan Yu, Ning Liu, Xiaogang Song, Lang Chen, Mancai Wang, Guohui Xiao, Tengfei Li, Zheyuan Wang and Youcheng Zhang
Cancers 2023, 15(2), 425; https://doi.org/10.3390/cancers15020425
Available online: https://www.mdpi.com/2072-6694/15/2/425

3. “Estrogen Receptor Signaling in Breast Cancer”
by Paulina Miziak, Marzena Baran, Ewa Błaszczak, Alicja Przybyszewska-Podstawka, Joanna Kałafut, Jolanta Smok-Kalwat, Magdalena Dmoszyńska-Graniczka, Michał Kiełbus and Andrzej Stepulak
Cancers 2023, 15(19), 4689; https://doi.org/10.3390/cancers15194689
Available online: https://www.mdpi.com/2072-6694/15/19/4689

4. “Mitochondrial Metabolism: A New Dimension of Personalized Oncology”
by Babak Behnam and Farzad Taghizadeh-Hesary
Cancers 2023, 15(16), 4058; https://doi.org/10.3390/cancers15164058
Available online: https://www.mdpi.com/2072-6694/15/16/4058

5. “Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance”
by Frank Eckerdt and Leonidas C. Platanias
Cancers 2023, 15(13), 3458; https://doi.org/10.3390/cancers15133458
Available online: https://www.mdpi.com/2072-6694/15/13/3458

6. “Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting”
by Payal Kapur, James Brugarolas and Kiril Trpkov
Cancers 2023, 15(16), 4043; https://doi.org/10.3390/cancers15164043
Available online: https://www.mdpi.com/2072-6694/15/16/4043

7. “The Role of Artificial Intelligence in the Detection and Implementation of Biomarkers for Hepatocellular Carcinoma: Outlook and Opportunities”
by Arian Mansur, Andrea Vrionis, Jonathan P. Charles, Kayesha Hancel, John C. Panagides, Farzad Moloudi, Shams Iqbal and Dania Daye
Cancers 2023, 15(11), 2928; https://doi.org/10.3390/cancers15112928
Available online: https://www.mdpi.com/2072-6694/15/11/2928

8. “Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions”
by Rendy Hosea, Sharon Hillary, Shourong Wu and Vivi Kasim
Cancers 2023, 15(13), 3506; https://doi.org/10.3390/cancers15133506
Available online: https://www.mdpi.com/2072-6694/15/13/3506

9. “New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer”
by Yang Zhao, Marisela Sheldon, Yutong Sun and Li Ma
Cancers 2023, 15(23), 5497; https://doi.org/10.3390/cancers15235497
Available online: https://www.mdpi.com/2072-6694/15/23/5497

10. “Oncotherapeutic Strategies in Early Onset Colorectal Cancer”
by Mary O’Reilly, Anna Linehan, Aleksandar Krstic, Walter Kolch, Kieran Sheahan, Des C. Winter and Ray Mc Dermott
Cancers 2023, 15(2), 552; https://doi.org/10.3390/cancers15020552
Available online: https://www.mdpi.com/2072-6694/15/2/552

11. “Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels”
by Zijian Zhu, Lai Jiang and Xianting Ding
Cancers 2023, 15(16), 4164; https://doi.org/10.3390/cancers15164164
Available online: https://www.mdpi.com/2072-6694/15/16/4164

12. “SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation”
by Md Gulam Musawwir Khan, Nadia Boufaied, Mehdi Yeganeh, Rajani Kandhi, Stephanie Petkiewicz, Ankur Sharma, Akihiko Yoshimura, Gerardo Ferbeyre, David P. Labbé, Sheela Ramanathan et al.
Cancers 2023, 15(3), 905; https://doi.org/10.3390/cancers15030905
Available online: https://www.mdpi.com/2072-6694/15/3/905

13. “Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques”
by Aldona Kasprzak
Cancers 2023, 15(18), 4570; https://doi.org/10.3390/cancers15184570
Available online: https://www.mdpi.com/2072-6694/15/18/4570

14. “Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology”
by Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Rohit Patil, Sanjay Singh, Dinesh Kumar and Ashish Kumar Agrawal
Cancers 2023, 15(9), 2661; https://doi.org/10.3390/cancers15092661
Available online: https://www.mdpi.com/2072-6694/15/9/2661

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Methods and Technologies Development”, which are listed below:

1. “Sentinel Lymph Node Biopsy in Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy: Clinical Experience with Node-Negative and Node-Positive Disease Prior to Systemic Therapy”
by Corrado Tinterri, Andrea Sagona, Erika Barbieri, Simone Di Maria Grimaldi, Giulia Caraceni, Giacomo Ambrogi, Flavia Jacobs, Ersilia Biondi, Lorenzo Scardina and Damiano Gentile
Cancers 2023, 15(6), 1719; https://doi.org/10.3390/cancers15061719
Available online: https://www.mdpi.com/2072-6694/15/6/1719

2. “Henry Gas Solubility Optimization Algorithm based Feature Extraction in Dermoscopic Images Analysis of Skin Cancer”
by Marwa Obayya, Adeeb Alhebri, Mashael Maashi, Ahmed S. Salama, Anwer Mustafa Hilal, Mohamed Ibrahim Alsaid, Azza Elneil Osman and Amani A. Alneil
Cancers 2023, 15(7), 2146; https://doi.org/10.3390/cancers15072146
Available online: https://www.mdpi.com/2072-6694/15/7/2146

3. “Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study”
by Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, Paolo Milani, Foteini Theodorakakou, Shlomzion Aumann, Noa Lavi, Liat Shargian, Hila Magen, Yael Cohen et al.
Cancers 2023, 15(6), 1710; https://doi.org/10.3390/cancers15061710
Available online: https://www.mdpi.com/2072-6694/15/6/1710

4. “Modern Surgical Techniques of Thyroidectomy and Advances in the Prevention and Treatment of Perioperative Complications”
by Bartłomiej Ludwig, Maksymilian Ludwig, Anna Dziekiewicz, Agnieszka Mikuła, Jakub Cisek, Szymon Biernat and Krzysztof Kaliszewski
Cancers 2023, 15(11), 2931; https://doi.org/10.3390/cancers15112931
Available online: https://www.mdpi.com/2072-6694/15/11/2931

5.“Empirical Study of Overfitting in Deep Learning for Predicting Breast Cancer Metastasis”
by Chuhan Xu, Pablo Coen-Pirani and Xia Jiang
Cancers 2023, 15(7), 1969; https://doi.org/10.3390/cancers15071969
Available online: https://www.mdpi.com/2072-6694/15/7/1969

6. “Raman Spectroscopic Imaging of Human Bladder Resectates towards Intraoperative Cancer Assessment”
by Christoph Krafft, Jürgen Popp, Peter Bronsert and Arkadiusz Miernik
Cancers 2023, 15(7), 2162; https://doi.org/10.3390/cancers15072162
Available online: https://www.mdpi.com/2072-6694/15/7/2162

7. “Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges”
by Wojciech Szymanowski, Anna Szymanowska, Anna Bielawska, Gabriel Lopez-Berestein, Cristian Rodriguez-Aguayo and Paola Amero
Cancers 2023, 15(21), 5300; https://doi.org/10.3390/cancers15215300
Available online: https://www.mdpi.com/2072-6694/15/21/5300

8. “Artificial Intelligence and Lung Cancer: Impact on Improving Patient Outcomes”
by Zainab Gandhi, Priyatham Gurram, Birendra Amgai, Sai Prasanna Lekkala, Alifya Lokhandwala, Suvidha Manne, Adil Mohammed, Hiren Koshiya, Nakeya Dewaswala, Rupak Desai et al.
Cancers 2023, 15(21), 5236; https://doi.org/10.3390/cancers15215236
Available online: https://www.mdpi.com/2072-6694/15/21/5236

9. “Performance and Safety of EUS Ablation Techniques for Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis”
by Apostolis Papaefthymiou, Gavin J. Johnson, Marcello Maida, Paraskevas Gkolfakis, Daryl Ramai, Antonio Facciorusso, Marianna Arvanitakis, Alexander Ney, Giuseppe K. Fusai, Adrian Saftoiu et al.
Cancers 2023, 15(9), 2627; https://doi.org/10.3390/cancers15092627
Available online: https://www.mdpi.com/2072-6694/15/9/2627

10. “Current and Future Use of Long Axial Field-of-View Positron Emission Tomography/Computed Tomography Scanners in Clinical Oncology”
by Mostafa Roya, Samaneh Mostafapour, Philipp Mohr, Laura Providência, Zekai Li, Johannes H. van Snick, Adrienne H. Brouwers, Walter Noordzij, Antoon T. M. Willemsen, Rudi A. J. O. Dierckx et al.
Cancers 2023, 15(21), 5173; https://doi.org/10.3390/cancers15215173
Available online: https://www.mdpi.com/2072-6694/15/21/5173

11. “Dung Beetle Optimization with Deep Feature Fusion Model for Lung Cancer Detection and Classification”
by Mohammad Alamgeer, Nuha Alruwais, Haya Mesfer Alshahrani, Abdullah Mohamed and Mohammed Assiri
Cancers 2023, 15(15), 3982; https://doi.org/10.3390/cancers15153982
Available online: https://www.mdpi.com/2072-6694/15/15/3982

12. “Micro-Ultrasound: Current Role in Prostate Cancer Diagnosis and Future Possibilities”
by Adriano Basso Dias and Sangeet Ghai
Cancers 2023, 15(4), 1280; https://doi.org/10.3390/cancers15041280
Available online: https://www.mdpi.com/2072-6694/15/4/1280

13. “Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles”
by Nisitha Wijewantha, Sanam Sane, Morgan Eikanger, Ryan M. Antony, Rashaun A. Potts, Lydia Lang, Khosrow Rezvani and Grigoriy Sereda
Cancers 2023, 15(4), 1145; https://doi.org/10.3390/cancers15041145
Available online: https://www.mdpi.com/2072-6694/15/4/1145

14. “PET/CT Imaging in Treatment Planning and Surveillance of Sinonasal Neoplasms”
by Sinan Akay, Janet H. Pollard, Assim Saad Eddin, Aiah Alatoum, Sedat Kandemirli, Ali Gholamrezanezhad, Yusuf Menda, Michael M. Graham and Ahmad Shariftabrizi
Cancers 2023, 15(15), 3759; https://doi.org/10.3390/cancers15153759
Available online: https://www.mdpi.com/2072-6694/15/15/3759

15. “Advancements in MRI-Based Radiomics and Artificial Intelligence for Prostate Cancer: A Comprehensive Review and Future Prospects”
by Ahmad Chaddad, Guina Tan, Xiaojuan Liang, Lama Hassan, Saima Rathore, Christian Desrosiers, Yousef Katib and Tamim Niazi
Cancers 2023, 15(15), 3839; https://doi.org/10.3390/cancers15153839
Available online: https://www.mdpi.com/2072-6694/15/15/3839

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

MDPI invites all experts recognized in their fields to attend the MDPI World Hepatitis Day Webinar 2024. Inspired by the collaborative spirit of World Hepatitis Day, this webinar aims to raise awareness about hepatitis and promote the development of innovative strategies to combat it. By engaging experts and the public, the webinar seeks to drive advancements and highlight the importance of collective efforts in scientific research and innovation.

We are looking forward to seeing you at the MDPI World Hepatitis Day Webinar 2024.

Title: MDPI World Hepatitis Day Webinar 2024
Date: 29 July 2024
Time: 15:00–17:00 (CEST) | 21:00–23:00 (CST Asia)
More Information: https://sciforum.net/event/WHD2024

This is a free webinar. After registration, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway and we will let you know when the recording is available for viewing.

Register for free:

Program:

Relevant Special Issues:

Animals
“Diseases of the Small and Large Intestine, Liver and Pancreas in Small Animals: Second Edition”
Edited by Dr. Alessio Pierini and Dr. Eleonora Gori
Deadline for submission: 20 December 2024

“Metabolic Disorders of Poultry”
Edited by Dr. Victoria Anthony Uyanga and Dr. Felix Kwame Amevor
Deadline for submission: 28 February 2025

Cancers
“Hepatitis Viruses and Cancer”
Edited by Prof. Dr. John Koskinas and Dr. Urania Georgopoulou
Deadline for submission: 1 November 2024

Cells
“Interdisciplinary Approaches to Studying Human Liver Biology and Promoting Organ Regeneration: Understanding the Curse of Prometheus”
Edited by Prof. Dr. David C. Hay, Dr. Matthew Sinton and Alvile Kasarinaite
Deadline for submission: N.A.

Children
“Old and New Therapeutic Strategies in Children with Liver Disease”
Edited by Dr. Raffaele Iorio and Dr. Fabiola Di Dato
Deadline for submission: 30 September 2024

Diagnostics
“Diagnosis, Management, and Prognosis of Liver Disease and Its Syndromes”
Edited by Prof. Dr. Chien Hao Huang
Deadline for submission: 31 August 2024

“Diagnostic and Prognostic Markers in Liver Diseases”
Edited by Dr. Dávid Tornai
Deadline for submission: 31 October 2024

“Diagnosis of Liver Disease”
Edited by Dr. Sung-Eun Kim
Deadline for submission: 31 December 2024

Gastroenterology Insights
“Novelties in Diagnostics and Therapeutics in Hepatology: 2nd Edition”
Edited by Dr. Giovanni Marasco and Dr. Matteo Renzulli
Deadline for submission: 31 December 2024

Journal of Personalized Medicine
“Chronic Liver Disease: New Targets and New Mechanisms”
Edited by Dr. Theodoros Androutsakos
Deadline for submission: 20 February 2025

Livers
“Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment”
Edited by Prof. Dr. Ralf Weiskirchen and Prof. Dr. Tilman Sauerbruch
Deadline for submission: 20 December 2024

Medicina
“Editorial Board Members’ Collection Series: Gastrointestinal and Hepatic Diseases”
Edited by Prof. Dr. Ludovico Abenavoli and Dr. Marcello Candelli
Deadline for submission: 24 December 2024

“Advances in Liver Surgery”
Edited by Prof. Dr. Jai Young Cho
Deadline for submission: 24 December 2024

“Novelties in Chronic Liver Diseases”
Edited by Prof. Dr. Ludovico Abenavoli
Deadline for submission: 30 September 2024

Metabolites
“Research on Pharmacotherapy of Metabolic-Associated Fatty Liver Disease”
Edited by Dr. Aleksandra Bołdys
Deadline for submission: 30 September 2024

“Metabolic Syndrome and Non-alcoholic Liver Disease”
Edited by Prof. Dr. Mircea-Catalin Fortofoiu, and Dr. Luigi Boccuto
Deadline for submission: 20 October 2024

“Liver Injury and Regeneration—Metabolic Research”
Edited by Dr. Miguel Suárez Matías
Deadline for submission: 31 December 2024

Microorganisms
“Hepatitis B Virus Infection and Vaccine”
Edited by Dr. Nishi N. Prabdial-Sing
Deadline for submission: 15 December 2024

Nutrients
“Metabolic-Dysfunction-Associated Steatotic Liver Disease at the Forefront: Confronting Nutritional Obstacles in Advanced Chronic Liver Disease and Portal Hypertension”
Edited by Dr. Angelo Armandi and Dr. Federico Ravaioli
Deadline for submission: 15 October 2024

“Prevention and Treatment of Liver Diseases by Dietary Habits and Lifestyle”
Dr. Marica Cariello and Dr. Raffaella Maria Gadaleta
Deadline for submission: 15 December 2024

“Managing Nonalcoholic Fatty Liver Disease with Nutrition”
Edited by Dr. Nobuyuki Toshikuni
Deadline for submission: 25 December 2024

Pathogens
“Zoonotic Hepatitis E Virus: A Focus on Animals, Food and Environment”
Edited by Prof. Dr. Barbara Di Martino, Dr. Federica Di Profio and Dr. Andrea Palombieri  
Deadline for submission: 10 October 2024

Vaccines
“Vaccines and Vaccination: HIV, Hepatitis Viruses, and HPV”
Edited by Dr. Ivan Schietroma and Dr. Sonia Moretti
Deadline for submission: 28 February 2025

“Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives”
Edited by Dr. Bárbara Vieira Do Lago and Dr. Vinicius M. Mello
Deadline for submission: 15 March 2025